GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 26551 - 26600 of 39437 in total
PDB ID ▲ UniProt ID Title Descriptor
7KY7 P42838 Structure of the S. cerevisiae phosphatidylcholine flippase Dnf2-Lem3 complex in the apo E1 state Alkylphosphocholine resistance protein LEM3, Phospholipid-transporting ATPase DNF2 (E.C.7.6.2.1)
7KY8 Q12675 Structure of the S. cerevisiae phosphatidylcholine flippase Dnf2-Lem3 complex in the E1-ATP state Phospholipid-transporting ATPase DNF2 (E.C.7.6.2.1), Alkylphosphocholine resistance protein LEM3
7KY8 P42838 Structure of the S. cerevisiae phosphatidylcholine flippase Dnf2-Lem3 complex in the E1-ATP state Phospholipid-transporting ATPase DNF2 (E.C.7.6.2.1), Alkylphosphocholine resistance protein LEM3
7KY9 Q12675 Structure of the S. cerevisiae phosphatidylcholine flippase Dnf2-Lem3 complex in the E1-ADP state Phospholipid-transporting ATPase DNF2 (E.C.7.6.2.1), Alkylphosphocholine resistance protein LEM3
7KY9 P42838 Structure of the S. cerevisiae phosphatidylcholine flippase Dnf2-Lem3 complex in the E1-ADP state Phospholipid-transporting ATPase DNF2 (E.C.7.6.2.1), Alkylphosphocholine resistance protein LEM3
7KYA Q12675 Structure of the S. cerevisiae phosphatidylcholine flippase Dnf2-Lem3 complex in the E2P state Phospholipid-transporting ATPase DNF2 (E.C.7.6.2.1), Alkylphosphocholine resistance protein LEM3
7KYA P42838 Structure of the S. cerevisiae phosphatidylcholine flippase Dnf2-Lem3 complex in the E2P state Phospholipid-transporting ATPase DNF2 (E.C.7.6.2.1), Alkylphosphocholine resistance protein LEM3
7KYB P32660 Structure of the S. cerevisiae phosphatidylcholine flippase Dnf1-Lem3 complex in the E1-ADP state Phospholipid-transporting ATPase DNF1 (E.C.7.6.2.1), Alkylphosphocholine resistance protein LEM3
7KYB P42838 Structure of the S. cerevisiae phosphatidylcholine flippase Dnf1-Lem3 complex in the E1-ADP state Phospholipid-transporting ATPase DNF1 (E.C.7.6.2.1), Alkylphosphocholine resistance protein LEM3
7KYC P32660 Structure of the S. cerevisiae phosphatidylcholine flippase Dnf1-Lem3 complex in the E2P state Phospholipid-transporting ATPase DNF1 (E.C.7.6.2.1), Alkylphosphocholine resistance protein LEM3
7KYC P42838 Structure of the S. cerevisiae phosphatidylcholine flippase Dnf1-Lem3 complex in the E2P state Phospholipid-transporting ATPase DNF1 (E.C.7.6.2.1), Alkylphosphocholine resistance protein LEM3
7KZ1 O95243 Human MBD4 glycosylase domain bound to DNA containing an abasic site
7KZ5 C0JRF5 Crystal structure of KabA from Bacillus cereus UW85 in complex with the plp external aldimine adduct with kanosamine-6-phosphate
7KZB 7KZB Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1antibodies
7KZB P0DTC2 Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1antibodies
7L02 P0DTC2 Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to one copy of domain-swapped antibody 2G12 2G12 heavy chain, 2G12 light chain, Spike glycoprotein
7L02 7L02 Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to one copy of domain-swapped antibody 2G12 2G12 heavy chain, 2G12 light chain, Spike glycoprotein
7L06 P0DTC2 Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to two copies of domain-swapped antibody 2G12 2G12 heavy chain, 2G12 light chain, Spike glycoprotein
7L06 7L06 Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to two copies of domain-swapped antibody 2G12 2G12 heavy chain, 2G12 light chain, Spike glycoprotein
7L09 P0DTC2 Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound domain-swapped antibody 2G12 from masked 3D refinement 2G12 heavy chain, 2G12 light chain, Spike glycoprotein
7L09 7L09 Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound domain-swapped antibody 2G12 from masked 3D refinement 2G12 heavy chain, 2G12 light chain, Spike glycoprotein
7L0J P03971 Structure of AMH bound to AMHR2-ECD
7L0J Q16671 Structure of AMH bound to AMHR2-ECD
7L0L Q4ZH98 Cryo-EM structure of the VRC316 clinical trial, vaccine-elicited, human antibody 316-310-1B11 in complex with an H2 CAN05 HA trimer
7L0L 7L0L Cryo-EM structure of the VRC316 clinical trial, vaccine-elicited, human antibody 316-310-1B11 in complex with an H2 CAN05 HA trimer
7L0N 7L0N Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
7L0N Q9BYF1 Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
7L0N P0DTC2 Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
7L15 7L15 Marsupial T cell receptor Spl_118
7L16 P30878 Crystal structure of sugar-bound melibiose permease MelB
7L17 P30878 Crystal structure of sugar-bound melibiose permease MelB
7L1Y 7L1Y Unlocking the structural features for the exo-xylobiosidase activity of an unusual GH11 member identified in a compost-derived consortium-xylobiose complex
7L21 P14618 Pyruvate Kinase M2 mutant-N70D
7L2C P0DTC2 Crystallographic structure of neutralizing antibody 2-51 in complex with SARS-CoV-2 spike N-terminal domain (NTD)
7L2C 7L2C Crystallographic structure of neutralizing antibody 2-51 in complex with SARS-CoV-2 spike N-terminal domain (NTD)
7L2D P0DTC2 Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein SARS-CoV-2 spike glycoprotein, 1-87 heavy chain, 1-87 light chain
7L2D 7L2D Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein SARS-CoV-2 spike glycoprotein, 1-87 heavy chain, 1-87 light chain
7L2E P0DTC2 Cryo-EM structure of NTD-directed neutralizing antibody 4-18 in complex with prefusion SARS-CoV-2 spike glycoprotein
7L2E 7L2E Cryo-EM structure of NTD-directed neutralizing antibody 4-18 in complex with prefusion SARS-CoV-2 spike glycoprotein
7L2F P0DTC2 Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein
7L2F 7L2F Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein
7L31 P23416 Cyro-EM structure of human Glycine Receptor alpha2-beta heteromer, strychnine bound state, 3.8 Angstrom
7L31 P42212 Cyro-EM structure of human Glycine Receptor alpha2-beta heteromer, strychnine bound state, 3.8 Angstrom
7L31 P48167 Cyro-EM structure of human Glycine Receptor alpha2-beta heteromer, strychnine bound state, 3.8 Angstrom
7L3N P0DTC2 SARS-CoV 2 Spike Protein bound to LY-CoV555 Spike glycoprotein, LY-CoV555 Fab heavy chain, LY-CoV555 Fab light chain
7L3N 7L3N SARS-CoV 2 Spike Protein bound to LY-CoV555 Spike glycoprotein, LY-CoV555 Fab heavy chain, LY-CoV555 Fab light chain
7L4Z P0DTC2 Structure of SARS-CoV-2 spike RBD in complex with cyclic peptide
7L4Z 7L4Z Structure of SARS-CoV-2 spike RBD in complex with cyclic peptide
7L56 P0DTC2 Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-43
7L56 7L56 Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-43

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024